Experts discuss the necessity of evolving prenatal care through innovative models to better meet patient needs and incorporate advances such as telemedicine.
In a recent interview, Alex Peahl, MD, MS, FACOG, Kimberly Malloy, MA, MD, FACOG, and Malini Nijagal, MD, FACOG, discussed their presentation about improving prenatal care at the 2024 ACOG Annual Clinical & Scientific Meeting.
For decades prior to the COVID-19 pandemic, little change was observed for prenatal care practices. The standard for prenatal care remained a 12-to-14 in-person visit schedule focused on identifying illness rather than promoting wellness.
This schedule led to some patients receiving too much care while others did not receive enough, and many received the wrong type of care. Following the COVID-19 pandemic, innovations such as telemedicine and use of targeted visit schedules changed how care is delivered.
According to Peahl, it is necessary to determine how to incorporate these practices into prenatal care. The session provided a foundation about why prenatal care needs to change and the tools necessary to innovate care.
Three models of prenatal care delivery were discussed during the presentation. The first was The Michigan Plan for Appropriate, Tailored Healthcare (MiPATH) in pregnancy. This model was developed during the COVID-19 pandemic to incorporate patient choice, educational needs, and social factors into care.
The second model discussed was a modified MiPATH prenatal care schedule. This model was utilized to support a growing need for prenatal care in clinics with a shortage of available clinical appointments.
Social needs that a clinic may not be equipped to managed has remained a concern at locations such as San Francisco General Hospital. These concerns can be managed through a cross-center collaborative where organizations come together to provide a “monthly, one-stop shop” where patients can access a diverse range of care services.
Peahl hoped doctors would walk away from the session understanding the importance of prenatal care. “We have 9 months to help people successfully navigate birth and the postpartum period, to help ensure that their health is optimized,” Peahl said, noting that the inpatient and outpatient settings are both important to support patient care.
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More